Retatrutide 10MG

Retatrutide is a cutting-edge triple receptor agonist targeting GLP-1, GIP and Glucagon

receptors showing exceptional promise for weight loss and metabolic health, with clinical

trials reporting up to 24% weight reduction over 48 weeks. By targeting multiple metabolic

pathways, it enhances energy expenditure, curbs appetite, and improves insulin sensitivity.

Ideal for individuals struggling with obesity or metabolic syndrome seeking next-generation,

research-backed therapeutic options under medical supervision

Potential Benefits

• Improves glucose and lipid metabolism, supporting long-term cardiometabolic wellness.
• Promotes liver health, with potential benefits for nonalcoholic fatty liver disease (NAFLD).
• Enhances energy expenditure and curb appetite.
• Demonstrated superior efficacy compared to single-agonist therapies such as semaglutide in early-phase studies.

Each unit includes a 3ml bottle of BA water.

⚠️ Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.

This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.